Cerus - 28 Year Stock Price History | CERS
- The all-time high Cerus stock closing price was 80.50 on December 28, 2000.
- The Cerus 52-week high stock price is 2.54, which is 74% above the current share price.
- The Cerus 52-week low stock price is 1.12, which is 23.3% below the current share price.
- The average Cerus stock price for the last 52 weeks is 1.70.
Cerus Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 1.5007 | 1.5700 | 2.1500 | 1.2200 | 1.4600 | -5.19% |
2024 | 1.9104 | 2.1600 | 2.4200 | 1.5200 | 1.5400 | -28.70% |
2023 | 2.2750 | 3.7400 | 3.8100 | 1.2500 | 2.1600 | -40.82% |
2022 | 4.7679 | 6.9900 | 6.9900 | 3.3800 | 3.6500 | -46.40% |
2021 | 6.3033 | 6.9400 | 7.9300 | 4.7900 | 6.8100 | -1.59% |
2020 | 5.8744 | 4.2500 | 8.5600 | 2.8700 | 6.9200 | 63.98% |
2019 | 5.3073 | 5.3400 | 6.8500 | 3.8400 | 4.2200 | -16.77% |
2018 | 5.9496 | 3.5600 | 7.7800 | 3.5600 | 5.0700 | 50.00% |
2017 | 3.3151 | 4.3300 | 4.6100 | 2.0200 | 3.3800 | -22.30% |
2016 | 5.8151 | 6.2400 | 7.3900 | 4.2200 | 4.3500 | -31.17% |
2015 | 5.0900 | 6.5150 | 6.5900 | 3.8600 | 6.3200 | 1.28% |
2014 | 4.7555 | 6.4800 | 7.9500 | 3.5000 | 6.2400 | -3.26% |
2013 | 5.0364 | 3.1900 | 6.9400 | 2.9500 | 6.4500 | 104.11% |
2012 | 3.3740 | 2.8600 | 4.3200 | 2.7600 | 3.1600 | 12.86% |
2011 | 2.7593 | 2.4800 | 3.5700 | 1.9800 | 2.8000 | 13.82% |
2010 | 2.8919 | 1.8000 | 3.9300 | 1.7800 | 2.4600 | 23.62% |
2009 | 1.4225 | 0.8200 | 2.9800 | 0.6200 | 1.9900 | 184.29% |
2008 | 4.3830 | 6.5600 | 7.2400 | 0.5800 | 0.7000 | -89.25% |
2007 | 6.9439 | 5.6800 | 10.1800 | 5.1300 | 6.5100 | 11.09% |
2006 | 7.9437 | 10.0100 | 14.4800 | 5.3100 | 5.8600 | -42.27% |
2005 | 5.7492 | 3.1000 | 11.3300 | 3.0500 | 10.1500 | 244.07% |
2004 | 2.9397 | 4.5000 | 4.7100 | 1.8500 | 2.9500 | -35.02% |
2003 | 7.4840 | 21.7200 | 21.7200 | 3.4000 | 4.5400 | -78.88% |
2002 | 33.4150 | 46.7700 | 58.6800 | 11.8700 | 21.5000 | -53.01% |
2001 | 55.9457 | 69.7500 | 75.3500 | 33.6250 | 45.7500 | -39.20% |
2000 | 49.3274 | 24.8750 | 80.5000 | 24.8750 | 75.2500 | 183.96% |
1999 | 23.9072 | 20.5000 | 31.2500 | 15.4375 | 26.5000 | 26.19% |
1998 | 16.4559 | 22.0000 | 23.7500 | 12.0000 | 21.0000 | -4.55% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.277B | $0.180B |
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $232.616B | 27.97 |
Boston Scientific (BSX) | United States | $153.611B | 38.46 |
Stryker (SYK) | United States | $149.817B | 31.33 |
EssilorLuxottica (ESLOY) | France | $128.259B | 0.00 |
Medtronic (MDT) | Ireland | $112.441B | 15.94 |
Lonza Group Ag (LZAGY) | Switzerland | $50.320B | 0.00 |
Haleon (HLN) | United Kingdom | $45.596B | 26.03 |
ResMed (RMD) | United States | $37.597B | 28.24 |
GE HealthCare Technologies (GEHC) | United States | $34.163B | 16.22 |
Agilent Technologies (A) | United States | $33.875B | 22.08 |
Terumo (TRUMY) | Japan | $24.770B | 32.17 |
Koninklijke Philips (PHG) | Netherlands | $22.956B | 16.11 |
Insulet (PODD) | United States | $21.162B | 83.07 |
Zimmer Biomet Holdings (ZBH) | United States | $18.315B | 11.76 |
Baxter (BAX) | United States | $15.236B | 11.38 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.113B | 0.00 |
Demant (WILYY) | Denmark | $8.971B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.723B | 23.40 |
Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
Prestige Consumer Healthcare (PBH) | United States | $3.900B | 17.42 |
Perrigo (PRGO) | Ireland | $3.676B | 9.32 |
Haemonetics (HAE) | United States | $3.609B | 16.44 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.334B | 27.70 |
ICU Medical (ICUI) | United States | $3.192B | 23.54 |
QuidelOrtho (QDEL) | United States | $1.976B | 13.59 |
LeMaitre Vascular (LMAT) | United States | $1.875B | 41.91 |
AtriCure (ATRC) | United States | $1.561B | 0.00 |
Acuren (TIC) | United States | $1.375B | 0.00 |
AdaptHealth (AHCO) | United States | $1.248B | 12.67 |
Phibro Animal Health (PAHC) | United States | $1.212B | 15.49 |
Green Thumb Industries (GTBIF) | United States | $1.163B | 26.16 |
Neogen (NEOG) | United States | $1.081B | 13.83 |
BioLife Solutions (BLFS) | United States | $1.036B | 0.00 |
InMode (INMD) | Israel | $0.954B | 9.62 |
Kestra Medical Technologies (KMTS) | United States | $0.757B | 0.00 |
Owens & Minor (OMI) | United States | $0.669B | 5.55 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.662B | 0.00 |
CeriBell (CBLL) | United States | $0.622B | 0.00 |
Evolus (EOLS) | United States | $0.589B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.507B | 0.00 |
Valneva SE (VALN) | France | $0.488B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
Surmodics (SRDX) | United States | $0.424B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.344B | 12.67 |
SNDL (SNDL) | Canada | $0.326B | 0.00 |
Quanterix (QTRX) | United States | $0.315B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.284B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
ZimVie (ZIMV) | United States | $0.263B | 11.94 |
Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
Brainsway (BWAY) | Israel | $0.253B | 66.85 |
Aurora Cannabis (ACB) | Canada | $0.249B | 73.83 |
Cresco Labs (CRLBF) | United States | $0.247B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.228B | 0.00 |
Canopy Growth (CGC) | Canada | $0.221B | 0.00 |
Biote (BTMD) | United States | $0.218B | 6.14 |
TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
High Tide (HITI) | Canada | $0.188B | 0.00 |
Organigram Global (OGI) | Canada | $0.186B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.186B | 15.13 |
Omeros (OMER) | United States | $0.180B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.173B | 0.00 |
Exagen (XGN) | United States | $0.148B | 0.00 |
Vireo Growth (VREOF) | United States | $0.147B | 0.00 |
FitLife Brands (FTLF) | United States | $0.129B | 15.90 |
Apyx Medical (APYX) | United States | $0.098B | 0.00 |
Fonar (FONR) | United States | $0.096B | 12.37 |
Jin Medical (ZJYL) | China | $0.090B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.088B | 0.00 |
MacroGenics (MGNX) | United States | $0.086B | 0.00 |
Veru (VERU) | United States | $0.086B | 0.00 |
Zynex (ZYXI) | United States | $0.076B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
Agape ATP (ATPC) | $0.070B | 0.00 | |
InterCure (INCR) | Israel | $0.068B | 0.00 |
Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.062B | 0.00 |
ImmuCell (ICCC) | United States | $0.059B | 0.00 |
Nephros (NEPH) | United States | $0.043B | 58.29 |
Modular Medical (MODD) | United States | $0.040B | 0.00 |
Safety Shot (SHOT) | United States | $0.038B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 13.10 |
Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
INLIF (INLF) | $0.015B | 0.00 | |
IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
Senestech (SNES) | United States | $0.012B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |